170 related articles for article (PubMed ID: 11353767)
1. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells.
Mayer IA; Verma A; Grumbach IM; Uddin S; Lekmine F; Ravandi F; Majchrzak B; Fujita S; Fish EN; Platanias LC
J Biol Chem; 2001 Jul; 276(30):28570-7. PubMed ID: 11353767
[TBL] [Abstract][Full Text] [Related]
2. Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib.
Dumka D; Puri P; Carayol N; Lumby C; Balachandran H; Schuster K; Verma AK; Terada LS; Platanias LC; Parmar S
Leuk Lymphoma; 2009 Dec; 50(12):2017-29. PubMed ID: 19672773
[TBL] [Abstract][Full Text] [Related]
3. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis.
Verma A; Deb DK; Sassano A; Uddin S; Varga J; Wickrema A; Platanias LC
J Biol Chem; 2002 Mar; 277(10):7726-35. PubMed ID: 11773065
[TBL] [Abstract][Full Text] [Related]
4. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway.
Kovarik P; Stoiber D; Eyers PA; Menghini R; Neininger A; Gaestel M; Cohen P; Decker T
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13956-61. PubMed ID: 10570180
[TBL] [Abstract][Full Text] [Related]
5. Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells.
Parmar S; Katsoulidis E; Verma A; Li Y; Sassano A; Lal L; Majchrzak B; Ravandi F; Tallman MS; Fish EN; Platanias LC
J Biol Chem; 2004 Jun; 279(24):25345-52. PubMed ID: 15056660
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
7. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells.
Bandyopadhyay G; Biswas T; Roy KC; Mandal S; Mandal C; Pal BC; Bhattacharya S; Rakshit S; Bhattacharya DK; Chaudhuri U; Konar A; Bandyopadhyay S
Blood; 2004 Oct; 104(8):2514-22. PubMed ID: 15226183
[TBL] [Abstract][Full Text] [Related]
8. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid.
Alsayed Y; Uddin S; Mahmud N; Lekmine F; Kalvakolanu DV; Minucci S; Bokoch G; Platanias LC
J Biol Chem; 2001 Feb; 276(6):4012-9. PubMed ID: 11060298
[TBL] [Abstract][Full Text] [Related]
9. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins.
Uddin S; Lekmine F; Sharma N; Majchrzak B; Mayer I; Young PR; Bokoch GM; Fish EN; Platanias LC
J Biol Chem; 2000 Sep; 275(36):27634-40. PubMed ID: 10878008
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.
Parmar S; Smith J; Sassano A; Uddin S; Katsoulidis E; Majchrzak B; Kambhampati S; Eklund EA; Tallman MS; Fish EN; Platanias LC
Blood; 2005 Oct; 106(7):2436-43. PubMed ID: 15790787
[TBL] [Abstract][Full Text] [Related]
11. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
Swart JM; Bergeron DM; Chiles TC
J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
[TBL] [Abstract][Full Text] [Related]
12. Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.
Müller-Tidow C; Kiehl M; Sindermann JR; Probst M; Banger N; Zühlsdorf M; Chou TC; Berdel WE; Serve H; Koch OM
Int J Oncol; 2003 Jul; 23(1):151-8. PubMed ID: 12792788
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells.
Kaur S; Parmar S; Smith J; Katsoulidis E; Li Y; Sassano A; Majchrzak B; Uddin S; Tallman MS; Fish EN; Platanias LC
Exp Hematol; 2005 May; 33(5):550-7. PubMed ID: 15850832
[TBL] [Abstract][Full Text] [Related]
14. Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells.
Grumbach IM; Mayer IA; Uddin S; Lekmine F; Majchrzak B; Yamauchi H; Fujita S; Druker B; Fish EN; Platanias LC
Br J Haematol; 2001 Feb; 112(2):327-36. PubMed ID: 11167825
[TBL] [Abstract][Full Text] [Related]
15. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling.
Platanias LC
Pharmacol Ther; 2003 May; 98(2):129-42. PubMed ID: 12725866
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes.
Kayali AG; Austin DA; Webster NJ
Diabetes; 2000 Nov; 49(11):1783-93. PubMed ID: 11078444
[TBL] [Abstract][Full Text] [Related]
17. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
18. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway.
Yu TK; Caudell EG; Smid C; Grimm EA
J Immunol; 2000 Jun; 164(12):6244-51. PubMed ID: 10843677
[TBL] [Abstract][Full Text] [Related]
19. Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils.
Krump E; Sanghera JS; Pelech SL; Furuya W; Grinstein S
J Biol Chem; 1997 Jan; 272(2):937-44. PubMed ID: 8995385
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p38 mitogen-activated protein kinase blocks activation of rat pancreatic stellate cells.
Masamune A; Satoh M; Kikuta K; Sakai Y; Satoh A; Shimosegawa T
J Pharmacol Exp Ther; 2003 Jan; 304(1):8-14. PubMed ID: 12490569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
